GUFICBIO logo

Gufic Biosciences LTD.

GUFICBIO·NSE·
420.35 +4.00 (+0.96%)
Market Cap4228.62 Cr
PE Ratio66.72
Volume94,410
Day High - Low426.25 - 414.60
52W High-Low448.00 - 268.00
DocStoX Score
4.6/10
Weak
Fair Value
Sign in to see
ROE
9.49%
Average
P/E
66.72x
Expensive
Debt / Equity
0.61
Moderate
Industry
Healthcare
Pharmaceuticals
Overall View
Mixed

Price performance

Day414.60
426.25
52W268.00
448.00
DocStoX take

Supported by momentum (7.5) and risk (7.0), but held back by valuation (0.0). Momentum looks strong at 7.5, but that is offset by valuation at 0.0. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence
4.6
/10
Weak
Quality
Modest
ROE 9.5%
Valuation
Expensive
P/E 66.7×
Growth
Slow
Revenue +14.1% 5Y CAGR
Risk
Moderate
D/E 0.61
Momentum
Strong
85% of 52-week range

At a glance

Market Cap
₹4,229 Cr
52W High / Low
₹448 / ₹268
Dividend Yield
0.02%
Promoter Holding
72.50%
EPS (TTM)
₹6.30
Book Value
₹66.40

Key highlights

  • Profitable in all of the last 5 years
  • Valuation is weak (0.0/10)
  • Expensive at 67× earnings
1 Positive2 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

GUFIC BIOSCIENCES LTD. peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.